Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of BK1301 in healthy adults
jRCT2080222663Phase 2
- Sponsor
- Research Foundation for Microbial Diseases of Osaka University
- Start
- Nov 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of TRIBIK in diphtheria, Tetanus and pertussis, sponsored by Research Foundation for Microbial Diseases of Osaka University.
02
Drugs
TRIBIK
03
Conditions
diphtheriaTetanuspertussis
Beyond the preview
Go deeper on jRCT2080222663.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222663.